Clearlake Capital Group has made an undisclosed investment in ModMed, a healthcare SaaS platform specializing in technology tailored for various medical specialties. Established in 2010, ModMed focuses on developing AI-driven solutions that cater to the needs of healthcare providers and their staff.

ModMed's offerings include a wide range of tools designed to enhance both clinical and operational efficiency. Their technology encompasses electronic health records (EHRs), practice management, revenue cycle management, patient engagement, payment processing, and native AI integrations. These solutions aim to streamline healthcare workflows and improve the overall patient experience.

According to Dan Cane and Dr. Michael Sherling, Co-CEOs and Co-Founders of ModMed, there is a growing market demand for AI-enabled technologies that enhance efficiency in healthcare practices. Providers are increasingly seeking ways to improve patient experiences while also reducing time and costs associated with their operations.

In terms of advisory roles, Morgan Stanley and JP Morgan Securities acted as financial advisors to Clearlake, while Sidley Austin provided legal counsel. For ModMed, Goldman Sachs served as the exclusive financial advisor, with Kirkland & Ellis and Paul, Weiss, Rifkind, Wharton & Garrison offering legal and finance counsel, respectively.